logo
ScreenersREIT EarningsREIT SectorsMarketplaceLearn
Logo

ENDRA Life Sciences Inc.

NDRA

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imā€¦ read more

Healthcare

Diagnostics & Research

6 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$4.83

Price

-0.72%

-$0.03

$4.86

Previous Close

$4.76

Open

Premium

52w Discount
Market Cap

$3.632m

Small

Price/Earnings

0x

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$211.600k

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$9.769m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$13.00

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$1.753m

$3.171m

Assets

$1.418m

Liabilities

$587.300k

Debt
Debt to Assets

18.5%

-0.1x

Debt to EBITDA
Free Cash Flow

-$6.556m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
ā†‘ TopSummaryPriceFinancialsPress Releases
logo
About usFAQ
All the information presented is collected from official and public documents such as: Quarterly and Annual Reports, 10-K (US), Information Form (Canada), Presentations and the Investor Relations (IR) section of the company's website.
The data displayed by alreits.com is solely for informational purposes, we do not recommend the buying, holding or selling of any of the stocks on the website. If you have no experience in the stock market, please talk to your personal licensed investment advisor before making any decisions.